Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer-Reference-Cited by-同舟云学术

Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer

Published:2019-06 Issue: Volume:452 Page:237-243
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wei Tao,Zhang Xiaoyu^ORCID,Zhang Qi,Yang Jiaqi,Chen Qi,Wang Jianxin,Li Xiang^ORCID,Chen Junye,Ma Tao,Li Guogang,Gao Shunliang,Lou Jianying,Que Risheng,Wang Yi,Dang Xiaowei,Zheng Lei^ORCID,Liang Tingbo,Bai Xueli

Funder

National High Technology Research and Development Program of China

National Natural Science Foundation of China

Key Research and Development Project of Zhejiang Province

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2015

2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014

3. Recurrence after resection for ductal adenocarcinoma of the pancreas;Sperti;World J. Surg.,1997

4. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma;Groot;Ann. Surg.,2018

5. Potential biomarkers in Lewis negative patients with pancreatic cancer;Luo;Ann. Surg.,2017

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. Circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers combined with clinicopathological risk has potential to better predict recurrence in stage III breast cancer treated with neoadjuvant chemotherapy: a pilot study;Breast Cancer Research and Treatment;2024-07-11

3. Changes of circulating tumor cells expressing CD90 and EpCAM in early-phase of atezolizumab and bevacizumab for hepatocellular carcinoma;Heliyon;2024-07

4. Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDAC;Cancers;2024-06-27

5. Can vimentin be an emerging early detection molecular biomarker in oral squamous cell carcinoma?;Oral Oncology Reports;2024-06